HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emery Polasek Selected Research

tabalumab

8/2014A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emery Polasek Research Topics

Disease

1Rheumatoid Arthritis
08/2014
1Rheumatic Diseases (Rheumatism)
08/2014

Drug/Important Bio-Agent (IBA)

1tabalumabIBA
08/2014
1Monoclonal AntibodiesIBA
08/2014
1C-Reactive ProteinIBA
08/2014
1B-Cell Activating FactorIBA
08/2014